Healthcare services
Healthcare providers, such as owners and operators of primary healthcare hospitals, retirement and nursing homes, have been hit the hardest by COVID-19. Almost all elective activity, including procedures and appointments, have been put on hold to prioritise the containment and treatment of the virus.
As a result, these companies face a reduction in their revenue and more uncertainty for their financial future. A number of smaller providers simply don’t have the financial resources to survive this temporary interruption in activities as we stay on an uncertain path to the “new normal”.
Based on Q1 2020 market data, Healthcare providers saw a 25% decrease in returns, followed by Med Tech and services with a 12% drop in returns. Biotech and Pharma sectors have proved to be most resilient with a consolidated market value of €1,460 bn and only a 5% and 7% drop in returns respectively.